Request for Covid-19 Impact Assessment of this Report

Automotive and Transportation

Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2022-2028

  • LP 4914760
  • 85 Pages
  • March 2022
  • Automotive and Transportation
Download Sample    Get Discount   
 
According to this study, the global Nucleic Acid Drugs market size will reach US$ million by 2028.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.

Segmentation by product type:

Antisense Nucleic Acid Drugs

siRNA Drugs

saRNA Drugs

miRNA Drugs

mRNA Drugs

other

Segmentation by Application:

Genetic Disease

Cancer

Cardiovascular Diseases

Other

This report also splits the market by region:

United States

China

Europe

Other regions:

Japan

South Korea

Southeast Asia

Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

Sarepta Therapeutics

Ionis Pharmaceuticals

Alnylam

Mina Therapeutics

BioNTech

NeXstar Pharmaceuticals

Nippon Shinyaku

Moderna Therapeutics

CureVac

Regulus Therapeutics

Miragen Therapeutics

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nucleic Acid Drugs Market Size 2022-2028

2.1.2 Nucleic Acid Drugs Market Size CAGR by Region

2.2 Nucleic Acid Drugs Segment by Type

2.2.1 Antisense Nucleic Acid Drugs

2.2.2 siRNA Drugs

2.2.3 saRNA Drugs

2.2.4 miRNA Drugs

2.2.5 mRNA Drugs

2.2.6 other

2.3 Nucleic Acid Drugs Market Size by Type

2.3.1 Global Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)

2.3.2 Global Nucleic Acid Drugs Market Size Growth Rate by Type (2022-2028)

2.4 Nucleic Acid Drugs Segment by Application

2.4.1 Genetic Disease

2.4.2 Cancer

2.4.3 Cardiovascular Diseases

2.4.4 Other

2.5 Nucleic Acid Drugs Market Size by Application

2.5.1 Global Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)

2.5.2 Global Nucleic Acid Drugs Market Size Growth Rate by Application (2022-2028)

3 Nucleic Acid Drugs Key Players

3.1 Date of Key Players Enter into Nucleic Acid Drugs

3.2 Key Players Nucleic Acid Drugs Product Offered

3.3 Key Players Nucleic Acid Drugs Funding/Investment Analysis

3.4 Funding/Investment

3.4.1 Funding/Investment by Regions

3.4.2 Funding/Investment by End-Industry

3.5 Key Players Nucleic Acid Drugs Valuation & Market Capitalization

3.6 Key Players Mergers & Acquisitions, Expansion Plans

3.7 Market Ranking

3.8 New Product/Technology Launches

3.9 Partnerships, Agreements, and Collaborations

3.10 Mergers and Acquisitions

4 Nucleic Acid Drugs by Regions

4.1 Nucleic Acid Drugs Market Size by Regions (2022-2028)

4.2 United States Nucleic Acid Drugs Market Size Growth (2022-2028)

4.3 China Nucleic Acid Drugs Market Size Growth (2022-2028)

4.4 Europe Nucleic Acid Drugs Market Size Growth (2022-2028)

4.5 Rest of World Nucleic Acid Drugs Market Size Growth (2022-2028)

5 United States

5.1 United States Nucleic Acid Drugs Market Size by Type (2022-2028)

5.2 United States Nucleic Acid Drugs Market Size by Application (2022-2028)

6 China

6.1 China Nucleic Acid Drugs Market Size by Type (2022-2028)

6.2 China Nucleic Acid Drugs Market Size by Application (2022-2028)

7 Europe

7.1 Europe Nucleic Acid Drugs Market Size by Type (2022-2028)

7.2 Europe Nucleic Acid Drugs Market Size by Application (2022-2028)

8 Rest of World

8.1 Rest of World Nucleic Acid Drugs Market Size by Type (2022-2028)

8.2 Rest of World Nucleic Acid Drugs Market Size by Application (2022-2028)

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Key Investors in Nucleic Acid Drugs

10.1 Company A

10.1.1 Company A Company Details

10.1.2 Company Description

10.1.3 Companies Invested by Company A

10.1.4 Company A Key Development and Market Layout

10.2 Company B

10.2.1 Company B Company Details

10.2.2 Company Description

10.2.3 Companies Invested by Company B

10.2.4 Company B Key Development and Market Layout

10.3 Company C

10.3.1 Company C Company Details

10.3.2 Company Description

10.3.3 Companies Invested by Company C

10.3.4 Company C Key Development and Market Layout

10.4 Company D

10.5 ……

11 Key Players Analysis

11.1 Sarepta Therapeutics

11.1.1 Sarepta Therapeutics Company Details

11.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Offered

11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

11.1.4 Sarepta Therapeutics Main Business Overview

11.1.5 Sarepta Therapeutics News

11.2 Ionis Pharmaceuticals

11.2.1 Ionis Pharmaceuticals Company Details

11.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered

11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2022 VS 2027)

11.2.4 Ionis Pharmaceuticals Main Business Overview

11.2.5 Ionis Pharmaceuticals News

11.3 Alnylam

11.3.1 Alnylam Company Details

11.3.2 Alnylam Nucleic Acid Drugs Product Offered

11.3.3 Alnylam Nucleic Acid Drugs Market Size (2022 VS 2027)

11.3.4 Alnylam Main Business Overview

11.3.5 Alnylam News

11.4 Mina Therapeutics

11.4.1 Mina Therapeutics Company Details

11.4.2 Mina Therapeutics Nucleic Acid Drugs Product Offered

11.4.3 Mina Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

11.4.4 Mina Therapeutics Main Business Overview

11.4.5 Mina Therapeutics News

11.5 BioNTech

11.5.1 BioNTech Company Details

11.5.2 BioNTech Nucleic Acid Drugs Product Offered

11.5.3 BioNTech Nucleic Acid Drugs Market Size (2022 VS 2027)

11.5.4 BioNTech Main Business Overview

11.5.5 BioNTech News

11.6 NeXstar Pharmaceuticals

11.6.1 NeXstar Pharmaceuticals Company Details

11.6.2 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offered

11.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2022 VS 2027)

11.6.4 NeXstar Pharmaceuticals Main Business Overview

11.6.5 NeXstar Pharmaceuticals News

11.7 Nippon Shinyaku

11.7.1 Nippon Shinyaku Company Details

11.7.2 Nippon Shinyaku Nucleic Acid Drugs Product Offered

11.7.3 Nippon Shinyaku Nucleic Acid Drugs Market Size (2022 VS 2027)

11.7.4 Nippon Shinyaku Main Business Overview

11.7.5 Nippon Shinyaku News

11.8 Moderna Therapeutics

11.8.1 Moderna Therapeutics Company Details

11.8.2 Moderna Therapeutics Nucleic Acid Drugs Product Offered

11.8.3 Moderna Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

11.8.4 Moderna Therapeutics Main Business Overview

11.8.5 Moderna Therapeutics News

11.9 CureVac

11.9.1 CureVac Company Details

11.9.2 CureVac Nucleic Acid Drugs Product Offered

11.9.3 CureVac Nucleic Acid Drugs Market Size (2022 VS 2027)

11.9.4 CureVac Main Business Overview

11.9.5 CureVac News

11.10 Regulus Therapeutics

11.10.1 Regulus Therapeutics Company Details

11.10.2 Regulus Therapeutics Nucleic Acid Drugs Product Offered

11.10.3 Regulus Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

11.10.4 Regulus Therapeutics Main Business Overview

11.10.5 Regulus Therapeutics News

11.11 Miragen Therapeutics

12 Research Findings and Conclusion

List of Tables

Table 1. Nucleic Acid Drugs Market Size CAGR by Region (2022-2028) ($ Millions)

Table 2. Major Players of Antisense Nucleic Acid Drugs

Table 3. Major Players of siRNA Drugs

Table 4. Major Players of saRNA Drugs

Table 5. Major Players of miRNA Drugs

Table 6. Major Players of mRNA Drugs

Table 7. Major Players of other

Table 8. Global Nucleic Acid Drugs Market Size by Type (2022-2028) ($ Millions)

Table 9. Global Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)

Table 10. Global Nucleic Acid Drugs Market Size by Application (2022-2028) ($ Millions)

Table 11. Global Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)

Table 12. Date of Global Key Players Enter into Nucleic Acid Drugs Market

Table 13. Global Key Players Nucleic Acid Drugs Product Offered

Table 14. Key Players Nucleic Acid Drugs Funding/Investment ($ Millions)

Table 15. Funding/Investment by Regions

Table 16. Funding/Investment by End Industry

Table 17. Key Players Nucleic Acid Drugs Valuation & Market Capitalization ($ Millions)

Table 18. Key Players Mergers & Acquisitions, Expansion Plans

Table 19. Nucleic Acid Drugs New Product/Technology Launches

Table 20. Nucleic Acid Drugs Industry Partnerships, Agreements, and Collaborations

Table 21. Nucleic Acid Drugs Industry Mergers and Acquisitions

Table 22. Global Nucleic Acid Drugs Market Size by Regions 2022-2028 ($ Millions)

Table 23. Global Nucleic Acid Drugs Market Size Market Share by Regions 2022-2028

Table 24. United States Nucleic Acid Drugs Market Size by Type (2022-2028) ($ Millions)

Table 25. United States Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)

Table 26. United States Nucleic Acid Drugs Market Size by Application (2022-2028) ($ Millions)

Table 27. United States Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)

Table 28. China Nucleic Acid Drugs Market Size by Type (2022-2028) ($ Millions)

Table 29. China Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)

Table 30. China Nucleic Acid Drugs Market Size by Application (2022-2028) ($ Millions)

Table 31. China Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)

Table 32. Europe Nucleic Acid Drugs Market Size by Type (2022-2028) ($ Millions)

Table 33. Europe Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)

Table 34. Europe Nucleic Acid Drugs Market Size by Application (2022-2028) ($ Millions)

Table 35. Europe Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)

Table 36. Rest of World Nucleic Acid Drugs Market Size by Type (2022-2028) ($ Millions)

Table 37. Rest of World Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)

Table 38. Rest of World Nucleic Acid Drugs Market Size by Application (2022-2028) ($ Millions)

Table 39. Rest of World Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)

Table 40. Key Market Drivers & Growth Opportunities of Nucleic Acid Drugs

Table 41. Key Market Challenges & Risks of Nucleic Acid Drugs

Table 42. Key Industry Trends of Nucleic Acid Drugs

Table 43. Company A Company Details

Table 44. Companies Invested by Company A

Table 45. Company A Key Development and Market Layout

Table 46. Company B Company Details

Table 47. Companies Invested by Company B

Table 48. Company B Key Development and Market Layout

Table 49. Company C Company Details

Table 50. Companies Invested by Company C

Table 51. Company C Key Development and Market Layout

Table 52. Company C Company Details

Table 53. Companies Invested by Company C

Table 54. Company C Key Development and Market Layout

Table 55. Sarepta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors

Table 56. Sarepta Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 57. Ionis Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors

Table 58. Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 59. Alnylam Basic Information, Head Office, Major Market Areas and Its Competitors

Table 60. Alnylam Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 61. Mina Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors

Table 62. Mina Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 63. BioNTech Basic Information, Head Office, Major Market Areas and Its Competitors

Table 64. BioNTech Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 65. NeXstar Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors

Table 66. NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 67. Nippon Shinyaku Basic Information, Head Office, Major Market Areas and Its Competitors

Table 68. Nippon Shinyaku Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 69. Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors

Table 70. Moderna Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 71. CureVac Basic Information, Head Office, Major Market Areas and Its Competitors

Table 72. CureVac Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 73. Regulus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors

Table 74. Regulus Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

Table 75. Miragen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors

Table 76. Miragen Therapeutics Nucleic Acid Drugs Market Size (2022 VS 2027)

List of Figures

Figure 1. Picture of Nucleic Acid Drugs

Figure 2. Nucleic Acid Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nucleic Acid Drugs Market Size Growth Rate 2022-2028 ($ Millions)

Figure 7. Nucleic Acid Drugs Market Size by Region (2022 & 2027) ($ millions)

Figure 8. Global Nucleic Acid Drugs Market Size Market Share by Type (2022-2028)

Figure 9. Global Antisense Nucleic Acid Drugs Market Size Growth Rate

Figure 10. Global siRNA Drugs Market Size Growth Rate

Figure 11. Global saRNA Drugs Market Size Growth Rate

Figure 12. Global miRNA Drugs Market Size Growth Rate

Figure 13. Global mRNA Drugs Market Size Growth Rate

Figure 14. Global other Market Size Growth Rate

Figure 15. Nucleic Acid Drugs in Genetic Disease

Figure 16. Global Nucleic Acid Drugs Market: Genetic Disease (2022-2028) ($ Millions)

Figure 17. Nucleic Acid Drugs in Cancer

Figure 18. Global Nucleic Acid Drugs Market: Cancer (2022-2028) ($ Millions)

Figure 19. Nucleic Acid Drugs in Cardiovascular Diseases

Figure 20. Global Nucleic Acid Drugs Market: Cardiovascular Diseases (2022-2028) ($ Millions)

Figure 21. Nucleic Acid Drugs in Other

Figure 22. Global Nucleic Acid Drugs Market: Other (2022-2028) ($ Millions)

Figure 23. Global Nucleic Acid Drugs Market Size Market Share by Application (2022-2028)

Figure 24. Global Nucleic Acid Drugs Market Size in Genetic Disease Growth Rate

Figure 25. Global Nucleic Acid Drugs Market Size in Cancer Growth Rate

Figure 26. Global Nucleic Acid Drugs Market Size in Cardiovascular Diseases Growth Rate

Figure 27. Global Nucleic Acid Drugs Market Size in Other Growth Rate

Figure 28. Funding/Investment

Figure 29. Global Nucleic Acid Drugs Market Size Market Share by Regions 2022-2028

Figure 30. United States Nucleic Acid Drugs Market Size 2022-2028 ($ Millions)

Figure 31. China Nucleic Acid Drugs Market Size 2022-2028 ($ Millions)

Figure 32. Europe Nucleic Acid Drugs Market Size 2022-2028 ($ Millions)

Figure 33. Rest of World Nucleic Acid Drugs Market Size 2022-2028 ($ Millions)

Figure 34. United States Nucleic Acid Drugs Consumption Market Share by Type in 2027

Figure 35. United States Nucleic Acid Drugs Market Size Market Share by Application in 2027

Figure 36. China Nucleic Acid Drugs Consumption Market Share by Type in 2027

Figure 37. China Nucleic Acid Drugs Market Size Market Share by Application in 2027

Figure 38. Europe Nucleic Acid Drugs Consumption Market Share by Type in 2027

Figure 39. Europe Nucleic Acid Drugs Market Size Market Share by Application in 2027

Figure 40. Rest of World Nucleic Acid Drugs Consumption Market Share by Type in 2027

Figure 41. Rest of World Nucleic Acid Drugs Market Size Market Share by Application in 2027

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Project Logistics Market in India 2011

The project logistics market in India is pegged at INR 200 bn in 2010 and is growing at a CAGR of 20%. Rapid core infrastructure development along with investment planned by the Government of India and private players will drive the project logistics market. The report begins with an introduction to the project logistics market in India, describing the types of cargo being transported and share...

  • Publish Date: January 3, 2011
  • $950
Luxury Car Market in India 2011

The luxury car market is expected to witness strong growth with rising number of foreign players planning expansions in the market. Growing number of young entrepreneurs in India inclined to drive luxury cars is brining about healthy demand for such cars. The report provides a brief overview of the automotive market in India, the production of passenger vehicles over years and the segmented share...

  • Publish Date: January 5, 2011
  • $950
Car Accessories Market in India 2011

In India, car accessories is a new concept which has gained popularity in recent times with growing usage of high end cars. The market can be divided into interior and exterior car accessories. In the Indian market, interior car accessories are more popular. The growing youth is providing a fillip to the market due to their perceptions and preferences. Although small cars are preferred by Indian c...

  • Publish Date: January 28, 2011
  • $950